Anthropic quietly sets up biology lab as it ramps AI drug program

Anthropic has established a biology lab to advance its AI drug program, aiming for Claude to direct laboratory robots with minimal human intervention. This initiative seeks to accelerate research into rare and historically "undruggable" diseases. The company plans to concentrate on preclinical research, thereby avoiding direct competition with pharmaceutical companies in clinical trials.